[{"Assets_0_Q3_USD":23671500000.0,"CIK":"872589","Country":"United States","EarningsPerShareBasic_1_Q3_USD":15.37,"EarningsPerShareBasic_3_Q3_USD":55.42,"EarningsPerShareDiluted_1_Q3_USD":14.33,"EarningsPerShareDiluted_3_Q3_USD":52.29,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"77738004554.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":4708800000.0,"NetIncomeLossConverted_1_Q3_USD":1632200000.0,"NetIncomeLossConverted_3_Q3_USD":5846300000.0,"OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","RevenuesConverted_1_Q3_USD":3452800000.0,"RevenuesConverted_3_Q3_USD":11120000000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquity_0_Q3_USD":17258000000.0,"Ticker":"REGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":113900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":111800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":106200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":105500000.0,"filed":"20211104","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2021.0","name":"REGENERON PHARMACEUTICALS, INC.","period":"20210930","qtrs":"0","uom":"USD"}]